And how the heck do you know it’s untrue???

FA did reply just not directly to that post. This was his reply:
‘Yes, my contact and friend is from hospital administration and is very aware of Brilacidin. There is hospital protocol for the administration and reporting of compassionately used drugs. The family has been messaged by many on Facebook and are aware many are investors so I don’t think you will have much luck getting a response from them. My friend handles IRB, informed consent and must report adverse reactions. HIPPA compliance is necessary so I can report generalizations. Family and staff do credit Brilacidin for the progress achieved.”

I think that should cover it. He is a well respected poster.

Thanks FA. That’s great news!

Any truth to this?

If they do know the data
then why would anyone order it for a hospital if the data was bad????

“Most likely requests came from trial sites”
This makes the most sense of all. Who else really even knows about Brilacidin? Not many.
But if these sites saw some patients suddenly make rapid turnarounds they could could reasonably surmise it was due to Brilacidin and therefore ask for compassionate use. Seems likely and very positive for Brilacidin!

Oh I am saying the trial was large enough
to get EUA but only with strong enough results to be absolutely conclusive. A larger trial with ok results might get EUA but at this size it will take very strong results. What very strong is I have no idea. I do believe however that even with decent results the share price will go to between $2 and $3. Not more because they will keep the market cap under a billion until further resting. With exceptional results though the sky is the limit…

Although a 120 subject trial may not
be enough to get EUA (it also may with exceptional results) or approval a successful result would lift IPIX up to at least $2 or $3 which would be a great start. Funds would likely flow in for a larger trial further propelling the price upward. Also if B proves successful it likely pave the way for trials involving many other viruses.
Bottom line in my opinion is 120 subject trial is enough to garner some very nice short term gains with very significant longer term gains to come.

Yes Nipah virus is enveloped.
NiV is an enveloped virus with two surface glycoproteins, G and F, that mediate entry into the host cell.

Agreed. Just trying to
liven this board up. We have waited a long time for this moment
and I see no reason to get negative now.
Go B…Go Leo…

Just needed funding/backing which it will get THIS time…

Time for Leo to
blow the lid off all these naysayers. B has never failed a trial…
Tic tock tic tock.

Actually I mean 10% better than
Remdesivir alone since the trial was with Remdesivir.
Good part about that is Gilead could get behind Brilacidin…

Just for thought sake
suppose Brilacidin is 10% better than Remdesivir.
What would the stock price get to?

I expect they don’t match if you take them to 4 or more decimal places…

Israeli drug phase 1 results:
https://www.jpost.com/health-science/10-serious-covid-patients-given-israeli-drug-leave-hospital-in-one-day-669564

Thanks, if it was recently added that would be a big deal
otherwise it does not mean much if anything.

When was IP added to the SRO list?

Just to be clear:
The OR is important-
“An organization that does not have a record of sales of FDA-regulated products will be deemed to be significantly regulated if its operations are predominately in fields regulated by FDA, OR if its research, development, or other business activities are reasonably expected to result in the development of products that are regulated by FDA.”

Love your facts. Thank you. How Dr Siegel gets to promoting this on FOX I don’t get. I believe he is a stand up guy...but who knows...$$$

Great info as usual Farrell...Thanks

Seems like a really low bar.

Just sent the author info about Brilacidin.
Figured it can’t hurt.

It would be immediate.
But it’s not happening.

Appears Leo wanted to wait to pr the peer review until the trial start. People will see the review and then look and see trials have started...could get exciting...

Expect it to be Gilead. Remdesivir although SOC is basically useless against Covid but has been pushed forward for 2 reasons: $$$ and there really is nothing else better...until B. We have had lab tests with REM and now human trials are happening. Like Rem or not it will pave the highway for B as long as results are what most of us expect. Without a BP to support B has a tough road but with Gilead needing to protect REM we have a golden highway...lots of $$$....

So how often has Leo been late with filings? Ever?
I’ve only been here a year so I don’t really recall any.
Looking back through news a few years I don’t see any.

So how many people outside those on this board know anything about Brilacidin? I am guessing maybe a couple hundred at most??? Not counting anyone involved with the trials.

Great day...
Dosing first patient (or more) news next week and forget $ .45...$1.45 next week...first positive (imo there will be no negative) $3.45 and then...WOW....

Perhaps put a portion of your shares at $20 bucks or so GTC (pick a number you like) and just hold the balance to see where things go.

Is Brilacidin available for Right to Try?

I expect that number counts each brokerage as one. Does not count individual investors.

“Why has there been no progress with FDA since all this stuff is old?”

Because this paper had to come out to get the ball rolling. I think we will have several more significant news pieces soon...

With the IND which looks inevitable to come (next week?) I would think government funding for the human trial would also become available. Thoughts?

I thought that the Eli Lilly drug had been dropped due to lack of effect?

Qualigen’s AS1411 to be tested in combination with Remdesivir - Louisville University lab.

I expect an update either Friday or Monday....

I expect after the NDA that the government will fund the 120 person trial...criminal if they don’t but politics do suck...so who knows....

Things here will look much better after or on the 23rd...it’s coming just be patient..

It was Regeneron.